Komori
Stella Chemifa (4109) · InitiativeReframedLatest General Meetings of Shareholders (2026-05-28): "Restated"

Expanding sales of other products, including stannous fluoride and concentrated boric acid

First written in FY2020. 8 of 13 entries say "Restated". Latest entry: 2026-05-28.

13entries
7years
2from disclosures
Share on X
How it moved
ProgressHeldSoftenedWorseRestatedFY2020 – FY2021-Q3RestatedFY2022-Q1 – FY2022-Q3ReframedFY2025 – FY2026-H12020: 220202021: 420212022: 120222023: 020232024: 220242025: 220252026: 22026
Same theme, other companies
Sales expansion of other chemical products, including stannous fluoride and concentrated boric acidA theme 1 companies write about · 0 as a headwind · 1 as a tailwind

No other company in this theme has enough history to compare yet.

Full recordFilings, disclosures and news, newest first
  1. FY2026-H1ReframedAnnual report

    「Profitability improved for stannous fluoride in the semiconductor and general products divisions due to price pass-through in response to higher raw material prices.」

    For other products, including stannous fluoride, the company cites improved profitability through passing on higher raw material costs as a contribution to results in addition to expanded sales.
  2. FY2025ReframedAnnual report

    「As another area of focus, we will seek to expand applications and sales of products related to growth fields, including fluorides for communications-related applications, where demand is expected to expand. Sales of enriched boric acid for use at nuclear-related facilities have grown steadily, but are currently concentrated in China. Taking country risk into account, we will seek to expand sales in line with energy policies in Japan, Europe, North America and other regions.」

    For other products, the company has added fluorides for communications-related applications as a growth field and stated its policy of expanding sales of enriched boric acid beyond its China-centered sales base into Japan, Europe, North America and other markets.
  3. FY2025-H1RestatedAnnual report

    「In addition to increased shipments of enriched boron (boron-10) used at nuclear-related facilities in the energy division, shipments in the general products division also increased. As a result, net sales were ¥15.826 billion, up 27.6% year on year.」

    Increased shipments in the energy division, including enriched boron for nuclear-related facilities, continue to be identified as a factor contributing to sales growth in the high-purity chemicals business.
  4. FY2024AdvancedAnnual report

    「In the energy division, we have upgraded and improved production facilities for enriched boron, for which demand is expected to remain strong, and established a system for more efficient production. We will work to expand sales going forward.」

    The company states that it has upgraded and improved production facilities for enriched boron and established an efficient production system.
  5. FY2022-Q3RestatedAnnual report

    「Sales of enriched boron (boron-10) used at nuclear-related facilities also contributed, and net sales were ¥27.124 billion, up 8.8% year on year.」

    Increased sales of enriched boron (boron-10) to nuclear-related facilities continue to be cited as a factor contributing to sales growth.
  6. FY2022-Q2RestatedAnnual report

    「Sales of enriched boron (boron-10) used at nuclear-related facilities also contributed, and net sales were ¥15.631 billion, up 8.6% year on year.」

    Increased sales of enriched boron (boron-10) to nuclear-related facilities contributed to sales growth in the high-purity chemicals business.
  7. FY2022-Q1RestatedAnnual report

    「Sales of enriched boron (boron-10) used at nuclear-related facilities also contributed, and net sales were ¥8.896 billion, up 8.2% year on year.」

    Increased sales of enriched boron (boron-10) to nuclear-related facilities continue to be cited as a factor contributing to overall sales growth.
  8. FY2021AdvancedAnnual report

    「Shipments of enriched boron (boron-10) used at nuclear-related facilities increased, mainly for use as a water source for specified severe accident response facilities in Japan.」

    Increased shipments of enriched boron (boron-10) were reported, mainly for use as a water source for specified severe accident response facilities in Japan.
  9. FY2021-Q3RestatedAnnual report

    「Sales of enriched boron (boron-10) used at nuclear-related facilities also contributed, and net sales were ¥24.927 billion, up 0.8% year on year.」

    Increased sales of enriched boron (boron-10) to nuclear-related facilities continue to be cited as a factor contributing to sales growth.
  10. FY2021-Q2RestatedAnnual report

    「In the high-purity chemicals business, profit increased due to sales of enriched boron (boron-10) used at nuclear-related facilities and lower prices for anhydrous hydrofluoric acid, a key raw material, compared with the same period of the previous year, reflecting supply and demand in the Chinese market and other factors.」

    Sales of enriched boron (boron-10) to nuclear-related facilities continue to be cited as one factor contributing to profit growth.
  11. FY2020First statedAnnual report

    「We will work to expand sales of stannous fluoride for toothpaste and enriched boric acid for nuclear power plants, among other products, with the aim of improving earnings.」

    Among products other than semiconductors and batteries, the company has identified expanding sales of stannous fluoride for toothpaste and enriched boric acid for nuclear power plants as priorities.
Moved together

"Uncertainty over the outlook due to the slowdown in emerging-market economies, yen appreciation and falling stock prices" moved the same way as this thread, in the same document, in 2 of its 13 moves.

222222★123456
  1. ★This thread
  2. 1Uncertainty over the outlook due to the slowdown in emerging-market economies, yen appreciation and falling stock prices2×
  3. 2Decline in income from the insurance agency business and other sources2×
  4. 3Strengthening sales in North America and Europe and expanding production capacity for high-purity chemicals used in semiconductors2×
  5. 4Development of Materials for Next-Generation Power Semiconductors and Energy Devices2×
  6. 5Management Target Monitoring Using Net Sales and Operating Income2×
  7. 6Dependence on Specific Sources, Including China, for Raw Materials and Exposure to Sharp Price Increases2×

★ is this thread; numbers match the list above. The number on a line is how many documents both moved the same way in; lines between the other threads count the documents they moved together in too. Threads that move together often sit closer.

When this could move next
No upcoming earnings preview for Stella Chemifa yet. It last moved in the General Meetings of Shareholders of 2026-05-28: "Restated".
News
No news is linked to this thread yet. When an article touches it, it will appear here by date.
Expanding sales of other products, including stannous fluoride and concentrated boric acid | STELLA CHEMIFA CORPORATION (4109) | Komori